Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-210: Hsa-mir-210 is a microRNA that has been extensively studied in various contexts [PMC5400787]. It has been associated significantly with mRNA in NCRM, and pathway analysis using QIAGEN Ingenuity Pathway Analysis was performed to understand its role [PMC5400787]. In a study involving HepG2 and HuH-7 cells, hsa-mir-210 was reverse transcribed from total RNA using the TaqMan® MicroRNA Reverse Transcription Kit [PMC6775050]. Hsa-mir-210 is one of the miRNAs found in a set of 24 models, along with other miRNAs such as hsa-miR-9 and hsa-miR-375 [PMC8870702]. In triple-negative breast cancer (TNBC) tissues and plasma, hsa-mir-210 is among the overexpressed miRNAs along with hsa-miR-19a and hsa-miR-19b [PMC5706292]. Hsa-mir-210 is known to be regulated by hypoxia and acts as a tumor suppressor by regulating tumor cell growth, angiogenesis, and apoptosis [PMC5221119]. In the context of hepatitis C virus (HCV), alterations in various miRNAs including hsa-mir-210 have been associated with HCV severity and liver function deterioration [PMC10138470].
mRNA interactions
15 total
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Localisation
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset
